-
Something wrong with this record ?
Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome
AL Schulz, B Albrecht, C Arici, der Burgt I van, A Buske, G Gillessen-Kaesbach, R Heller, D Horn, CA Hubner, GC Korenke, R Konig, W Kress, G Kruger, P Meinecke, J Mucke, B Plecko, E Rossier, A Schinzel, A Schulze, E Seemanova, H Seidel, S...
Language English Country Denmark
Document type Research Support, Non-U.S. Gov't
Grant support
NR7916
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
Wiley Online Library (archiv)
from 1997-01-01 to 2012-12-31
PubMed
18042262
Knihovny.cz E-resources
- MeSH
- Child MeSH
- Adult MeSH
- Facies * MeSH
- Phenotype MeSH
- Skin Abnormalities * genetics MeSH
- Humans MeSH
- MAP Kinase Kinase 1 genetics MeSH
- MAP Kinase Kinase 2 genetics MeSH
- Intellectual Disability MeSH
- Abnormalities, Multiple * genetics MeSH
- Mutation * MeSH
- DNA Mutational Analysis MeSH
- Proto-Oncogene Proteins B-raf genetics MeSH
- Proto-Oncogene Proteins genetics MeSH
- ras Proteins genetics MeSH
- Syndrome MeSH
- Heart Defects, Congenital * genetics MeSH
- Developmental Disabilities MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
Cardio-facio-cutaneous (CFC) and Costello syndrome (CS) are congenital disorders with a significant clinical overlap. The recent discovery of heterozygous mutations in genes encoding components of the RAS-RAF-MAPK pathway in both CFC and CS suggested a similar underlying pathogenesis of these two disorders. While CFC is heterogeneous with mutations in BRAF, MAP2K1, MAP2K2 and KRAS, HRAS alterations are almost exclusively associated with CS. We carried out a comprehensive mutation analysis in 51 CFC-affected patients and 31 individuals with CS. Twelve different BRAF alterations were found in twenty-four patients with CFC (47.0%), two MAP2K1 mutations in five (9.8%) and two MAP2K2 sequence variations in three CFC-affected individuals (5.9%), whereas three patients had a KRAS alteration (5.9%). We identified four different missense mutations of HRAS in twenty-eight cases with CS (90.3%), while KRAS mutations were detected in two infants with a phenotype meeting criteria for CS (6.5%). In 14 informative families, we traced the parental origin of HRAS alterations and demonstrated inheritance of the mutated allele exclusively from the father, further confirming a paternal bias in the parental origin of HRAS mutations in CS. Careful clinical evaluation of patients with BRAF and MAP2K1/2 alterations revealed the presence of slight phenotypic differences regarding craniofacial features in MAP2K1- and MAP2K2-mutation positive individuals, suggesting possible genotype-phenotype correlations.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13033513
- 003
- CZ-PrNML
- 005
- 20131105155918.0
- 007
- ta
- 008
- 131016s2008 dk f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)18042262
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Schulz, A. L. $u Institut fur Humangenetik, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany
- 245 10
- $a Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome / $c AL Schulz, B Albrecht, C Arici, der Burgt I van, A Buske, G Gillessen-Kaesbach, R Heller, D Horn, CA Hubner, GC Korenke, R Konig, W Kress, G Kruger, P Meinecke, J Mucke, B Plecko, E Rossier, A Schinzel, A Schulze, E Seemanova, H Seidel, S Spranger, B Tuysuz, S Uhrig, D Wieczorek, K Kutsche, M Zenker
- 504 __
- $a Literatura
- 520 9_
- $a Cardio-facio-cutaneous (CFC) and Costello syndrome (CS) are congenital disorders with a significant clinical overlap. The recent discovery of heterozygous mutations in genes encoding components of the RAS-RAF-MAPK pathway in both CFC and CS suggested a similar underlying pathogenesis of these two disorders. While CFC is heterogeneous with mutations in BRAF, MAP2K1, MAP2K2 and KRAS, HRAS alterations are almost exclusively associated with CS. We carried out a comprehensive mutation analysis in 51 CFC-affected patients and 31 individuals with CS. Twelve different BRAF alterations were found in twenty-four patients with CFC (47.0%), two MAP2K1 mutations in five (9.8%) and two MAP2K2 sequence variations in three CFC-affected individuals (5.9%), whereas three patients had a KRAS alteration (5.9%). We identified four different missense mutations of HRAS in twenty-eight cases with CS (90.3%), while KRAS mutations were detected in two infants with a phenotype meeting criteria for CS (6.5%). In 14 informative families, we traced the parental origin of HRAS alterations and demonstrated inheritance of the mutated allele exclusively from the father, further confirming a paternal bias in the parental origin of HRAS mutations in CS. Careful clinical evaluation of patients with BRAF and MAP2K1/2 alterations revealed the presence of slight phenotypic differences regarding craniofacial features in MAP2K1- and MAP2K2-mutation positive individuals, suggesting possible genotype-phenotype correlations.
- 590 __
- $a bohemika - dle Pubmed
- 650 12
- $a mnohočetné abnormality $x genetika $7 D000015
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a dítě $7 D002648
- 650 02
- $a mutační analýza DNA $7 D004252
- 650 02
- $a vývojové poruchy u dětí $7 D002658
- 650 12
- $a faciální stigmatizace $7 D019066
- 650 12
- $a vrozené srdeční vady $x genetika $7 D006330
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mentální retardace $7 D008607
- 650 02
- $a MAP kinasa-kinasa 1 $x genetika $7 D048369
- 650 02
- $a MAP kinasa-kinasa 2 $x genetika $7 D048370
- 650 12
- $a mutace $7 D009154
- 650 02
- $a fenotyp $7 D010641
- 650 02
- $a protoonkogenní proteiny $x genetika $7 D011518
- 650 02
- $a protoonkogenní proteiny B-raf $x genetika $7 D048493
- 650 12
- $a kožní abnormality $x genetika $7 D012868
- 650 02
- $a syndrom $7 D013577
- 650 02
- $a ras proteiny $x genetika $7 D018631
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Albrecht, B. $7 gn_A_00003534
- 700 1_
- $a Arici, C. $7 gn_A_00008426
- 700 1_
- $a van der Burgt, I.
- 700 1_
- $a Buske, A.
- 700 1_
- $a Gillessen-Kaesbach, G.
- 700 1_
- $a Heller, R.
- 700 1_
- $a Horn, D.
- 700 1_
- $a Hubner, C. A.
- 700 1_
- $a Korenke, G. C.
- 700 1_
- $a Konig, R.
- 700 1_
- $a Kress, W.
- 700 1_
- $a Kruger, G.
- 700 1_
- $a Meinecke, P.
- 700 1_
- $a Mucke, J.
- 700 1_
- $a Plecko, B.
- 700 1_
- $a Rossier, E.
- 700 1_
- $a Schinzel, A.
- 700 1_
- $a Schulze, A.
- 700 1_
- $a Seemanová, Eva, $d 1939-2020 $7 jn20000620329 $u Institute of Biology and Medical Genetics, Charles Universtity, University Hospital Prague, Prague, Czech Republic
- 700 1_
- $a Seidel, H.
- 700 1_
- $a Spranger, S.
- 700 1_
- $a Tuysuz, B.
- 700 1_
- $a Uhrig, S.
- 700 1_
- $a Wieczorek, D.
- 700 1_
- $a Kutsche, K.
- 700 1_
- $a Zenker, M.
- 773 0_
- $t Clinical Genetics $g Roč. 73, č. 1 (2008), s. 62-70 $p Clin Genet $x 0009-9163 $w MED00001127
- 773 0_
- $p Clin Genet $g 73(1):62-70, 2008 Jan
- 910 __
- $a ABA008 $b A 3882 $y 3 $z 0
- 990 __
- $a 20131016101244 $b ABA008
- 991 __
- $a 20131105160437 $b ABA008
- 999 __
- $a ok $b bmc $g 997604 $s 831969
- BAS __
- $a 3
- BMC __
- $a 2008 $b 73 $c 1 $d 62-70 $i 0009-9163 $m Clinical genetics $x MED00001127 $n Clin Genet
- GRA __
- $a NR7916 $p MZ0
- LZP __
- $a 2013-10/dpbo